BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32936949)

  • 21. Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.
    Pollock A; Campbell P; Cheyne J; Cowie J; Davis B; McCallum J; McGill K; Elders A; Hagen S; McClurg D; Torrens C; Maxwell M
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013779. PubMed ID: 33150970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saline irrigation for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Glew S; Scadding G; Burton MJ; Schilder AG
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011995. PubMed ID: 27115216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal corticosteroids for non-allergic rhinitis.
    Segboer C; Gevorgyan A; Avdeeva K; Chusakul S; Kanjanaumporn J; Aeumjaturapat S; Reeskamp LF; Snidvongs K; Fokkens W
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31677153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
    Chatterjee P; Anand T; Singh KJ; Rasaily R; Singh R; Das S; Singh H; Praharaj I; Gangakhedkar RR; Bhargava B; Panda S
    Indian J Med Res; 2020 May; 151(5):459-467. PubMed ID: 32611916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
    Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
    Frank S; Capriotti J; Brown SM; Tessema B
    Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidance for otolaryngology health care workers performing aerosol generating medical procedures during the COVID-19 pandemic.
    Lammers MJW; Lea J; Westerberg BD
    J Otolaryngol Head Neck Surg; 2020 Jun; 49(1):36. PubMed ID: 32493489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction.
    O'Byrne L; Webster KE; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013876. PubMed ID: 36062970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?
    Casale M; Rinaldi V; Sabatino L; Moffa A; Ciccozzi M
    Int J Immunopathol Pharmacol; 2020; 34():2058738420941757. PubMed ID: 32799596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Will healthcare workers improve infection prevention and control behaviors as COVID-19 risk emerges and increases, in China?
    Lai X; Wang X; Yang Q; Xu X; Tang Y; Liu C; Tan L; Lai R; Wang H; Zhang X; Zhou Q; Chen H
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):83. PubMed ID: 32527300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personal protective equipment (PPE) and infection among healthcare workers - What is the evidence?
    Tian Z; Stedman M; Whyte M; Anderson SG; Thomson G; Heald A
    Int J Clin Pract; 2020 Nov; 74(11):e13617. PubMed ID: 32734641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need of health policy perspective to protect Healthcare Workers during COVID-19 pandemic. A GRADE rapid review on the N95 respirators effectiveness.
    Iannone P; Castellini G; Coclite D; Napoletano A; Fauci AJ; Iacorossi L; D'Angelo D; Renzi C; La Torre G; Mastroianni CM; Gianola S
    PLoS One; 2020; 15(6):e0234025. PubMed ID: 32492045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
    Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013877. PubMed ID: 34291812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19.
    Sommerstein R; Fux CA; Vuichard-Gysin D; Abbas M; Marschall J; Balmelli C; Troillet N; Harbarth S; Schlegel M; Widmer A;
    Antimicrob Resist Infect Control; 2020 Jul; 9(1):100. PubMed ID: 32631450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.